Use of crosslinked hemoglobin product in the treatment of...

Details Use of crosslinked hemoglobin product in the treatment of... Use of crosslinked hemoglobin product in the treatment of...

A - Human Necessities

61

K

A61K 38/42 (2006.01) A61K 35/18 (2006.01) A61M 1/14 (2006.01)

Patent

CA 2269258

Administration of low doses of crosslinked human hemoglobin product minimizes damage to the extremities after blockage and significantly reduces ischemic injury. Crosslinked human hemoglobin product exerts a pharmacological effect by increasing perfusion and alleviating ischemic injury.

Affiliated with

Also associated with

Rating

Use of crosslinked hemoglobin product in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of crosslinked hemoglobin product in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of crosslinked hemoglobin product in the treatment of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1520669